By Harvey Han, Utku Kaya, Omar Kanaa, Nayoung Kim, Tomiwa Oshai (King’s College London) and Nikhil Freiherr Raitz Von Frentz, Max Fischer, Daniel Barker, Moritz Ibe (University of St Andrews) Photo: Getty Images (Unsplash) Overview of the deal Acquirer: Lone Star Funds Target:  Hillenbrand Inc. Implied Equity Value: $3.8 billion ($32 per share) Total Transaction Size:  $3.8 billion (All-cash) Closed date:  The end of 1Q 2026 (Expected) Target Advisors: Jefferies LLC, UBS Inve

By Mateo Rafael Roman Sy, Nathaline Marielle Lukito, Nguyen Thi Hong Linh, Parth Talwar, and Jeongmin Oh (The University of Hong Kong), Edoardo Roveda, Alesha Jaswal, Mikhail Sinev, and Cooper Wu (University College London) Photo: Crystal Kwok Overview of the deal Acquirer: Berkshire Hathaway Target:  OxyChem Implied Equity Value: $9.7 Billion Total Transaction Size:  $9.7 Billion Closed date:  October 2, 2025 Target advisor: Barclays (Financials), Cravath, Swaine & Moore LLP

By Zoe Thaller, Arthus Marande (ESCP); Amya Hillis, Abraham Vongkhamdy, Irene Souny Bihr, Leo Fridjhon, Janira Martinez, Christian...

By Moritz Ibe, Ben Preece, Avital Anoff, Annant Bhargava (University of St Andrews); Haci Eren Sidar, Leon Gaster, Adalia Melvin, Aviral...

By Giulia Biagioli (Bocconi University); Giorgio Goretti and Marco Morchio (ESADE) Photo: Xibei Jia (Unsplash) Overview of the deal...

By Jack Liang, Anastasia Malikova, Shir Lyn Lau, Hunter Pang (LSE); Maximilien Kender, Jules Bedrossian and Amin Ouamar (HEC Paris) Photo:...

By Yuyu Huang, Kelly Liu, Jenny Sun, Henry Yao (John Hopkins University) ; Pierre Caye, Cédrik Nadeau (McGill University) Photo: ...

By Pierre Caye (McGill University), Jonathan Lui, Erica Chan, Hunter Pang, Lasheeka Ramesh (London School of Economics) Photo: Thomas...

By Rui Ren Lee, Ardia Daniswara, Varun Vinay Iyengar, Wei Kai Lim (KCL) & Mikolaj Borowiak, Argyro Charizona, Angelo Passaro, Rares...